Novo Nordisk (NVO) Stock Price Prediction: BMO’s higher target meets a mixed technical tape

Novo Nordisk (NVO) is trading at $41.30, above its short- and medium-term moving averages, while BMO Capital Markets lifted its target to $44 and kept a Market Perform rating on November 5, 2026. T… (Read More)

​